ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas | University of California, Davis Medical Center / Paul Knoepfler, PhD | Innovation Grants | 2015 | California |
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies | University of California, Davis Medical Center / Paul Knoepfler, PhD | Innovation Grants | 2017 | California |
Overcoming Obstacles to Drug Development in Pediatric Cancer | Stanford University School of Medicine / Crystal L. Mackall, MD | Crazy 8 Pilots | 2019 | California |
Multiplex Ion Beam Imaging of Pediatric Cancers | Stanford University School of Medicine / Crystal L. Mackall, MD | Crazy 8 Pilots | 2019 | California |
Single-Cell Profiling of Acute Myeloid Leukemia for High-Resolution Chemo-immunotherapy Target Discovery | Stanford University School of Medicine / Charles Gawad, MD/PhD | Single-cell Pediatric Cancer Atlas Grant | 2019 | California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells | Stanford University School of Medicine / Alice Bertaina, MD/PhD | Reach Grants | 2019 | California |
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma | Beckman Research Institute of City of Hope / Margarita Gutova, MD | Reach Grants | 2013 | California |
A Novel Target for Neuroblastoma Treatment | Beckman Research Institute of City of Hope / Linda Malkas, Ph.D. | Reach Grants | 2014 | California |
Saturating CRISPR gene body scans in MLL-rearranged leukemia | Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD | Innovation Grants | 2019 | California |
The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia | Children’s Hospital & Research Center at Oakland / Cheryl Peretz, MD | Young Investigator Grants | 2019 | California |
Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells | University of California Berkeley / Erin Simonds, PhD | Young Investigator Grants | 2013 | California |
Role of Fetal Growth in Pediatric Rhabdomyosarcoma | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2013 | California |
Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2014 | California |
Space-Time Analysis of the California Birth Cohort: 30 Years of Childhood Cancer | University of California Berkeley / Steve Selvin, PhD | Epidemiology Grants | 2015 | California |
Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC) | University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD | Epidemiology Grants | 2016 | California |
Endocrine Disrupting Pesticides, Neonatal Hormones and Risk of Testicular Germ Cell Tumors | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2018 | California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma | The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD | 'A' Award Grants | 2019 | California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias | University of California at Santa Cruz / Camilla Forsberg, PhD | Innovation Grants | 2013 | California |
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma | University of California at Santa Cruz / David Haussler, PhD | Innovation Grants | 2015 | California |
Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers | University of California at Santa Cruz / Seth Rubin, PhD | Innovation Grants | 2017 | California |
Harmonizing Data Sharing Efforts towards a Federated Data Model | University of California at Santa Cruz / Olena M. Vaske, PhD & David Haussler, PhD | Crazy 8 Pilots | 2019 | California |
Pain and Symptom Experiences in Children with Cancer | University of California, Los Angeles / Eufemia Jacob, PhD, RN | Nurse Researcher Grants | 2007 | California |
Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion | University of California, Los Angeles / Ren Sun, PhD | Springboard Grants | 2013 | California |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies | University of California, Los Angeles / Steven Jonas, MD/PhD | Young Investigator Grants | 2017 | California |
Maternal Comorbidities, Pharmaceutical Use and Childhood Cancers: A Record Linkage Study in Taiwan | University of California, Los Angeles / Julia Heck, PhD | Epidemiology Grants | 2017 | California |
Single-cell Profiling of Pediatric Bone Sarcomas | University of California, Los Angeles / Alice Soragni, PhD | Single-cell Pediatric Cancer Atlas Grant | 2019 | California |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds | University of California, San Diego / David Traver, MD | Innovation Grants | 2010 | California |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma | University of California, San Diego / Alice Yu, MD, PhD | Innovation Grants | 2011 | California |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds | University of California, San Diego / David Traver, MD | Innovation Grants | 2012 | California |
Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance | University of California, San Diego / Paolo Abada | Young Investigator Grants | 2012 | California |
Phase II Trial of Poly-ICLC in Pediatric Low Grade Gliomas | University of California, San Diego / Donald Durden, MD, PhD | Springboard Grants | 2013 | California |
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials | University of California, San Diego / Paula Aristizabal, MD | Psychosocial Grants | 2015 | California |
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer | The Regents of the University of California, Irvine / Michelle Fortier, PhD | Psychosocial Family Impact Grant | 2019 | California |
Enhancing TKI Therapy in Ph-Like Leukemia | The Regents of the University of California, Irvine / David Fruman, PhD | Reach Grants | 2022 | California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma | City of Hope National Medical Center / Linda Malkas, PhD | Reach Grants | 2019 | California |
Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase | City of Hope National Medical Center / Ling Li, PhD | R Accelerated Award Grants | 2023 | California |
The Identification of Neuroblastoma Cancer Stem Cells. | Stanford University / Robert Cho | Young Investigator Grants | 2007 | California |
Modeling osteosarcoma to identify novel therapeutic targets. | Stanford University / Julien Sage | Young Investigator Grants | 2006 | California |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia | Stanford University / Kara Davis | Young Investigator Grants | 2010 | California |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells | Stanford University / Hon-Kit Wong | Young Investigator Grants | 2010 | California |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells | Stanford University / Ramin Dubey, PhD | Young Investigator Grants | 2015 | California |
Single Cell Analysis of Leukemia Initiation | Stanford University / Michael Cleary, MD | Innovation Grants | 2015 | California |
Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford | Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D. | Phase I/II Infrastructure Grants | 2015 | California |
Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML | Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD | Reach Grants | 2015 | California |
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model | Stanford University / Michelle Monje, MD/PhD | Innovation Grants | 2016 | California |
Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model | Stanford University / Michelle Monje, MD/PhD | Innovation Grants | 2016 | California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) | Stanford University / Michelle Monje, MD, PhD | 'A' Award Grants | 2011 | California |
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations | Stanford University / Ravi Majeti, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | California |
Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma | Stanford University / Julien Sage, PhD | Innovation Grants | 2018 | California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis | Stanford University / Feng Pan, PhD | Young Investigator Grants | 2019 | California |
Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors | Harbor - UCLA Medical Center / Joseph Lasky | Young Investigator Grants | 2008 | California |
Blockade of Mycn in neuroblastoma | University of California San Francisco / William Weiss | Innovation Grants | 2008 | California |
131-I-MIBG and Targeted Therapy for Neuroblastoma: Infrastructure Proposal. | University of California San Francisco / Katherine Matthay, MD | Phase I/II Infrastructure Grants | 2007 | California |
Application of Epigenetic Markers for Early Detection of Childhood Leukemia. | University of California San Francisco / Sheng Zhong | Epidemiology Grants | 2008 | California |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL). | University of California San Francisco / Michelle Hermiston, MD, PhD | Young Investigator Grants | 2009 | California |
Optimizing EGFR targeted therapy in pediatric malignant glioma. | University of California San Francisco / Theodore Nicolaides | Young Investigator Grants | 2009 | California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer | University of California San Francisco / Tina Baggott, RN, PhD, PNP | Nurse Researcher Grants | 2009 | California |
131 I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal | University of California San Francisco / Katherine Matthay, MD | Phase I/II Infrastructure Grants | 2010 | California |
Long-Term Morbidity in Survivors of Childhood Cancer with Down Syndrome | University of California San Francisco / Shannon Raber | Nurse Researcher Grants | 2010 | California |
Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model | University of California San Francisco / Jean Nakamura | Young Investigator Grants | 2011 | California |
Blockade of MYCN in neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2011 | California |
Targeting inhibitory phosphatase signaling in high-risk childhood ALL | University of California San Francisco / Markus Muschen, MD, PhD | Innovation Grants | 2011 | California |
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma | University of California San Francisco / William Clay Gustafson, MD, PhD | 'A' Award Grants | 2011 | California |
Pediatric Developmental Therapeutics Center of Excellence at UCSF | University of California San Francisco / Katherine Matthay, MD, Kieuhoa Vo, MD, - Scholars: Amit Sabnis, MD, Lena Winestone, MD/MSHP, Beth Winger, MD/PhD, Bo Qiu, MD/PhD | Center of Excellence Grants | 2012 | California |
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma | University of California San Francisco / Miller Huang, PhD | Young Investigator Grants | 2013 | California |
Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia | University of California San Francisco / Mignon Loh, M.D. | Innovation Grants | 2014 | California |
Targeting eEF2 Kinase in Neuroblastoma | University of California San Francisco / William Weiss, M.D., Ph.D. | Innovation Grants | 2014 | California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome | University of California San Francisco / Adam de Smith, Ph.D. | 'A' Award Grants | 2014 | California |
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma | University of California San Francisco / Ozlem Aksoy, PhD | Young Investigator Grants | 2015 | California |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma | University of California San Francisco / Zhenyi An, PhD | Young Investigator Grants | 2015 | California |
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia | University of California San Francisco / Elliot Stieglitz, MD | Young Investigator Grants | 2015 | California |
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias | University of California San Francisco / Jeroen Roose, PhD | Innovation Grants | 2015 | California |
A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair | University of California San Francisco / Asmin Tulpule, MD/PhD | Young Investigator Grants | 2016 | California |
Investigating Racial Disparities in Pediatric Acute Leukemia | University of California San Francisco / Lena Winestone, MD | Young Investigator Grants | 2016 | California |
Overcoming Glucocorticoid Resistance in Lymphoid Cancers | University of California San Francisco / Anica Wandler, PhD | Young Investigator Grants | 2017 | California |
Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2018 | California |
A comprehensive public resource for fusion-negative sarcoma sequencing data | University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD | Crazy 8 Pilots | 2019 | California |
Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma | University of California San Francisco / Zulekha Qadeer, PhD | Young Investigator Grants | 2019 | California |
In-vivo characterization of MYCN-driven immunosuppression | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2021 | California |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma | University of California San Francisco / Elizabeth Young, MD | Young Investigator Grants | 2021 | California |
Understanding and inhibiting mechanisms of metastatic spread in osteosarcoma | University of California San Francisco / Alejandro Sweet-Cordero, MD | Crazy 8 Awards | 2022 | California |
Novel Resilience Genes Required for Cerebellum Development and Medulloblastoma Survival | University of California San Francisco / Stephen Fancy, PhD, DVM | Innovation Grants | 2023 | California |
Neural Crest Gene Regulatory Networks Underlying Normal Meningeal Development and Onset of Meningioma | California Institute of Technology / Ayyappa Raja Desingu Rajan, PhD | Young Investigator Grants | 2021 | California |
Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors | University of California, Davis / Wolf-Dietrich Heyer, PhD | Innovation Grants | 2018 | California |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma | Board of Trustees of the Leland Stanford Junior University / Michelle Monje | Catalyst Grants | 2021 | California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas | Cedars-Sinai Medical Center / Sandra Orsulic, PhD | Innovation Grants | 2013 | California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia | Children’s Hospital Los Angeles / Markus Muschen | Innovation Grants | 2008 | California |
Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors | Children’s Hospital Los Angeles / William May | Innovation Grants | 2008 | California |
New Approaches to Neuroblastoma Therapy | Children’s Hospital Los Angeles / Robert Seeger | Phase I/II Infrastructure Grants | 2008 | California |
Genomic Alterations in Medulloblastoma | Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD | Young Investigator Grants | 2008 | California |
Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors | Children’s Hospital Los Angeles / Jonathan Finlay, MD | Phase I/II Infrastructure Grants | 2007 | California |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture | Children’s Hospital Los Angeles / Theresa Harned, MD | Young Investigator Grants | 2006 | California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium | Children’s Hospital Los Angeles / Robert Seeger, MD | Phase I/II Infrastructure Grants | 2006 | California |
Central Venous Catheter (CVC) - Related Bloodstream Infections in Pediatric Cancer | Children’s Hospital Los Angeles / Rita Secola | Nurse Researcher Grants | 2009 | California |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors | Children’s Hospital Los Angeles / Mary Nelson | Nurse Researcher Grants | 2009 | California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature | Children’s Hospital Los Angeles / Robert Seeger | Innovation Grants | 2010 | California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma | Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD | Innovation Grants | 2015 | California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma | Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD | Innovation Grants | 2015 | California |
Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia | Children’s Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD | Reach Grants | 2015 | California |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma | Children’s Hospital Los Angeles / Sunhye Lee, PhD | Young Investigator Grants | 2016 | California |
Altered Cerebral Blood Flow after Pediatric Posterior Fossa Brain Tumor Treatment | Children’s Hospital Los Angeles / Mary Baron Nelson, RN/PhD | Nurse Researcher Grants | 2016 | California |
Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress | Children’s Hospital Los Angeles / Jessica Ward, PhD | Nurse Researcher Fellowship Grant | 2017 | California |
Circulating Repetitive Element RNAs as an Osteosarcoma Marker | Children’s Hospital Los Angeles / David Cobrinik, MD/PhD | Innovation Grants | 2018 | California |
Physical Properties of Drug-Resistant Leukemia Cells | Children’s Hospital Los Angeles / Yong-mi Kim, MD/PhD | Innovation Grants | 2018 | California |
Identifying Ewing Sarcoma Developmental Vulnerabilities | Children’s Hospital Los Angeles / Elena Vasileva, PhD | Young Investigator Grants | 2023 | California |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma | Children’s Hospital Los Angeles / Jesse Berry, MD | Reach Grants | 2023 | California |
Development of a comprehensive liquid biopsy-based genomics platform for pediatric solid tumors | Children’s Hospital Los Angeles / Jaclyn Biegel | Catalyst Grants | 2023 | California |
Studying the clonal dynamics and evolution of leukemia using molecular barcodes | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD | Innovation Grants | 2011 | California |
Improving Thymus Function by RB Inactivation | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Julien Sage, PhD | Springboard Grants | 2012 | California |
Reversing the Oncogenic Roles of Misdirected Chromatin Remodeling in Synovial Sarcoma | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Cigall Kadoch, PhD | Young Investigator Grants | 2013 | California |
Oncogenic Hedgehog Pathway Activation by a Putative Rho GTPase-Activating Protein | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Jun Ni, PhD | Young Investigator Grants | 2013 | California |
Next-Generation Therapies for Hedgehog Pathway-Dependent Tumors | Lucile Packard Children’s Hospital at Stanford University School of Medicine / James Chen, PhD | Innovation Grants | 2013 | California |
Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD | Young Investigator Grants | 2014 | California |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD | Young Investigator Grants | 2014 | California |
Modeling Anaplastic Medulloblastoma using Cerebellar Stem Cells | Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, PhD | Innovation Grants | 2011 | California |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma | Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. | Innovation Grants | 2014 | California |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma | The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. | Reach Grants | 2014 | California |
Detection of Circulating Tumor DNA in Pediatric Sarcomas | The Regents of the University of California San Francisco / Alejandro Sweet-Cordero, MD & Maximillian Diehn, MD/PhD (Stanford University) | Innovation Grants | 2016 | California |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders | The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | California |
Targeting Oncogenic N-MYC Complexes in High-Risk Neuroblastoma | The Regents of the University of California San Francisco / Bo Qiu, MD/PhD | Young Investigator Grants | 2023 | California |
CLL-1 CAR-T cells with or without trametinib for the treatment of JMML | The Regents of the University of California San Francisco / Elliot Stieglitz, MD | R Accelerated Award Grants | 2023 | California |
Enhancing Immunotherapy of Neuroblastoma | The Regents of the University of California, San Diego / Alice Yu, MD/PhD & Mitchell Diccianni, PhD | Innovation Grants | 2016 | California |